Congress orders study on why gynecologic patients can't get pain relief
H.R. 8159 — Gynecologic Pain Management Study Act · Filed by Yassamin Ansari (D-AZ) · 28 cosponsors · Introduced Mar 30, 2026 · Referred to committee
Your members of Congress
Enter a ZIP to see where your representative and both senators stood on this bill.
Looked up on this device — your ZIP is never stored on our servers.
What it does
This bill directs the Department of Health and Human Services to study why patients undergoing gynecologic procedures often lack access to pain management options. The study will examine barriers such as insurance coverage gaps, provider training deficiencies, and resource constraints, and will consult patients, doctors, medical societies, and device makers. HHS must report findings and recommendations to Congress within 24 months.
Why we flagged it
The bill is a straightforward directive for a government study on a documented healthcare access gap. It creates no new programs, subsidies, or regulatory changes—only a fact-finding obligation with a 24-month reporting deadline.
What the text implies
- Study findings may expose insurance industry practices that restrict coverage for pain management during gynecologic procedures, potentially creating political pressure for coverage mandates.
- Inclusion of medical device manufacturers in stakeholder consultation may influence recommendations toward device-based solutions (e.g., regional anesthesia equipment) rather than pharmaceutical or procedural alternatives.
- Report recommendations could trigger follow-up legislation mandating insurance coverage, provider training standards, or facility requirements—expanding federal healthcare regulation.
Section numbers refer to the bill text the analysis read — linked under Primary records below.
Who it affects
Patients undergoing gynecologic procedures gain transparency about why pain management is often unavailable and a pathway to policy solutions. The study directly addresses a documented gap in reproductive healthcare access without imposing costs or restrictions on patients or providers.
Who stands to gain
- medical device manufacturers (if recommendations favor device-based pain management solutions)
Named in the bill
Department of Health and Human Services, House Committee on Energy and Commerce, Senate Committee on Health, Education, Labor, and Pensions, patient advocacy organizations, reproductive health care providers, professional medical societies, medical device manufacturers
Where it stands
28 cosponsors: 28 Democrats.
- Mar 30, 2026 — Introduced · Congress.gov: “Introduced in House”
- Mar 30, 2026 — Referred to House Committee on Energy and Commerce · Congress.gov: “Referred to the House Committee on Energy and Commerce”
Dates and quoted wording are Congress.gov's action record; the timeline shows status changes, not every procedural step.
Money around this bill
1 lobbying clients named this bill on 1 disclosure filings across 1 quarter, Jun 2026 to Jun 2026. Those filings disclosed $96,000 in lobbying spend. A filing names 31 bills on average, so that figure is what each filing reported, not a share belonging to this bill.
More lobbying clients named this bill than 0% of bills with at least one filing.
Yassamin Ansari, the sponsor, reported $234,033 in PAC receipts in the 2026 cycle.
- American College of Obstetricians and Gynecologists — $96,000 on 1 filing
Lobbying Disclosure Act filings through Jul 20, 2026. A filing shows who paid to lobby on a bill it names, not what changed.
How this was measured
Analysis — Quorum's AI read the bill text published by Congress.gov (1,672 characters) on Apr 14, 2026. Section numbers in the findings refer to that text, linked below; transparency and hidden-provision scores are compared against the median of 16,222 analysed bills.
Status and sponsors — Congress.gov's bill record — actions, committee referrals and cosponsors — loaded nightly. The timeline shows status changes, not every procedural action.
Money — Senate Lobbying Disclosure Act filings whose specific-issue field names this bill for quarters ending Jun 2026 to Jun 2026. A filing's amount is reported whole beside the median number of bills a filing names; it is never divided across them. PAC receipts are FEC-reported contributions to the sponsor's candidate committee in the 2026 cycle.
As of — lobbying records through Jul 20, 2026 · page rendered 2026-10-20.
“Congress orders study on why gynecologic patients can't get pain relief” QuorumCivic. https://share.quorumcivic.app/bill/119/hr8159 Report an error
The week in bills
One email, Sunday: what Congress passed, what it changed, and who paid.
One link arrives to confirm the address. It is used for this email and nothing else, and every issue carries an unsubscribe link.